Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Pende

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Design|September 17, 2016
Editorial: Cardiovascular Prevention: Can We Do Any Better?Aldo Pende
Current Pharmaceutical Design|January 31, 2012
Inhibition of the renin-angiotensin-aldosterone system: how to obtain thisAldo Pende, Fabrizio Montecucco
Current Pharmaceutical Biotechnology|April 8, 2011
Anti-inflammatory approaches to reduce acute cardiovascular events: not only benefitsAldo Pende, Franco Dallegri
Current Pharmaceutical Design|January 31, 2012
Renin-angiotensin antagonists: therapeutic effects beyond blood pressure control?Aldo Pende, Franco Dallegri
Current Vascular Pharmacology|November 6, 2013
Is the carotid plaque rupture a pivotal event in stroke pathogenesis? Update on the role of the intraplaque inflammatory processesAldo Pende, Franco Dallegri
Drug Metabolism Letters|January 2, 2013
Update on the evidence of statin treatment to reduce plaque vulnerabilityFabrizio Montecucco, Aldo Pende
Cardiovascular Ultrasound|September 24, 2008
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjectsAldo Pende, Caterina Grondona, Stefano Bertolini
Mediators of Inflammation|April 25, 2009
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesFabrizio Montecucco, Aldo Pende, François Mach
Mediators of Inflammation|May 28, 2013
Inflammation is a key pathophysiological feature of metabolic syndromeFabrizio Montecucco, François Mach, Aldo Pende
Current Vascular Pharmacology|May 19, 2015
Editorial: is ischemic stroke an inflammatory disease?Valentina Garibotto, Aldo Pende, Fabrizio Montecucco
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|September 17, 2016
Editorial: Cardiovascular Prevention: Can We Do Any Better?Aldo Pende
Current Pharmaceutical Design|January 31, 2012
Inhibition of the renin-angiotensin-aldosterone system: how to obtain thisAldo Pende, Fabrizio Montecucco
Current Pharmaceutical Biotechnology|April 8, 2011
Anti-inflammatory approaches to reduce acute cardiovascular events: not only benefitsAldo Pende, Franco Dallegri
Current Pharmaceutical Design|January 31, 2012
Renin-angiotensin antagonists: therapeutic effects beyond blood pressure control?Aldo Pende, Franco Dallegri
Current Vascular Pharmacology|November 6, 2013
Is the carotid plaque rupture a pivotal event in stroke pathogenesis? Update on the role of the intraplaque inflammatory processesAldo Pende, Franco Dallegri
Drug Metabolism Letters|January 2, 2013
Update on the evidence of statin treatment to reduce plaque vulnerabilityFabrizio Montecucco, Aldo Pende
Cardiovascular Ultrasound|September 24, 2008
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjectsAldo Pende, Caterina Grondona, Stefano Bertolini
Mediators of Inflammation|April 25, 2009
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesFabrizio Montecucco, Aldo Pende, François Mach
Mediators of Inflammation|May 28, 2013
Inflammation is a key pathophysiological feature of metabolic syndromeFabrizio Montecucco, François Mach, Aldo Pende
Current Vascular Pharmacology|May 19, 2015
Editorial: is ischemic stroke an inflammatory disease?Valentina Garibotto, Aldo Pende, Fabrizio Montecucco
Pageof 6